Product was sterilized with a higher than specification EO concentration.
Source facts
Action
A customer letter dated 04/05/2022 was issued to impacted consignees. The letter instructs the following:
1) Review your inventory and segregate affected product. This product should not be shipped out to customers.
2) Return affected product to 2610 NE Industrial Drive, Suite 220, Kansas City, MO 64120.
3) If product was already further distributed, ensure that all downstream customers are properly notified of the recall and maintain records of effectiveness.
A Field Action Response Form should be completed and returned to suzanne.thomas@hyh.com, even if you do not have product inventory.
Initiated
2022-03-22
Root cause
Process control
Distribution
US Nationwide distribution in the states of IL, MO, NE, and TX.
Recall number
Z-1037-2022
Recall status
Open, Classified
CDRH record ID
192764
FDA record created
2022-05-06
Recall event number
89868
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.